Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lagrutta, M
~ 0  Ergebnisse:
Personensuche X
?
1

Serum 25-hydroxyvitamin D (25OHD) concentrations in hospita..:

Brance, M.L. ; Miljevic, J. ; Lagrutta, M....
Bone.  105 (2017)  - p. 305-306 , 2017
Link: https://doi.org/10.1016/..
 
?
2

La L-FABP moviliza el ácido araquidónico desde y hacia las ..:

Layerenza, Juan Pablo ; Lagrutta, M ; Sisti, María Susana.
http://sedici.unlp.edu.ar/handle/10915/18065.  , 2011
Link: http://sedici.unlp.edu.a..
 
?
3

Análisis de las proteínas de las gotas lipídicas nucleares:

Lagrutta, M ; Layerenza, Juan Pablo ; Sisti, María Susana.
http://sedici.unlp.edu.ar/handle/10915/18058.  , 2011
Link: http://sedici.unlp.edu.a..
 
?
4

Mastocitos azul alciano positivos en la mucosa del ciego de..:

Bassan, Norberto ; Vinuesa, Miguel ; Perez, F...
http://sedici.unlp.edu.ar/handle/10915/11090.  , 1998
Link: http://sedici.unlp.edu.a..
 
?
5

Author Correction: The state of the art in secondary pharma..:

Brennan, Richard J. ; Jenkinson, Stephen ; Brown, Andrew...
Nature Reviews Drug Discovery.  23 (2024)  7 - p. 563-563 , 2024
Link: https://doi.org/10.1038/..
 
?
6

The state of the art in secondary pharmacology and its impa..:

Brennan, Richard J. ; Jenkinson, Stephen ; Brown, Andrew...
Nature Reviews Drug Discovery.  23 (2024)  7 - p. 525-545 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Effect of starvation and pesticide exposure on neutral lipi..:

Lavarías, S.M.L. ; Peterson, G.B. ; Lagrutta, L.C....
Aquatic Toxicology.  255 (2023)  - p. 106397 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Time for a Fully Integrated Nonclinical–Clinical Risk Asses..:

Vargas, Hugo M. ; Rolf, Michael G. ; Wisialowski, Todd A....
Clinical Pharmacology & Therapeutics.  109 (2020)  2 - p. 310-318 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Metabolic syndrome in HIV-infected middle-aged women on ant..:

Akl, Lívia D. ; Valadares, Ana L.R. ; Moraes, Monica Jacques de...
The Brazilian Journal of Infectious Diseases.  21 (2017)  3 - p. 263-269 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel..:

Singh, Sheo B. ; Kaelin, David E. ; Wu, Jin...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  9 - p. 1831-1835 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Structure activity relationship of substituted 1,5-naphthyr..:

Singh, Sheo B. ; Kaelin, David E. ; Wu, Jin...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  11 - p. 2409-2415 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-link..:

Singh, Sheo B. ; Kaelin, David E. ; Wu, Jin...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  12 - p. 2473-2478 , 2015
Link: https://doi.org/10.1016/..
 
?
13

C1–C2-linker substituted 1,5-naphthyridine analogues of oxa..:

Singh, Sheo B. ; Kaelin, David E. ; Wu, Jin...
MedChemComm.  6 (2015)  10 - p. 1773-1780 , 2015
Link: https://doi.org/10.1039/..
 
?
14

Structure activity relationship of C-2 ether substituted 1,..:

Singh, Sheo B. ; Kaelin, David E. ; Meinke, Peter T....
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  17 - p. 3630-3635 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Preclinical pharmacology and pharmacokinetics of CERC‐301, ..:

Garner, Rachel ; Gopalakrishnan, Shobha ; McCauley, John A....
Pharmacology Research & Perspectives.  3 (2015)  6 - p. , 2015
Link: https://doi.org/10.1002/..
 
1-15